Necitumumab

From WikiMD.org
Jump to navigation Jump to search
Necitumumab
TermNecitumumab
Short definitionnecitumumab - (pronounced) (NEH-sih-TOO-moo-mab) drug used with gemcitabine and cisplatin to treat squamous non-small cell lung cancer that has spread to other parts of the body. It is used in patients whose cancer has not been treated with any other cancer therapy. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


necitumumab - (pronounced) (NEH-sih-TOO-moo-mab) drug used with gemcitabine and cisplatin to treat squamous non-small cell lung cancer that has spread to other parts of the body. It is used in patients whose cancer has not been treated with any other cancer therapy. It is also being studied in the treatment of other types of cancer. Necitumumab attaches to a protein called epidermal growth factor receptor (EGFR), which is found on some types of cancer cells. Blocking this protein can help prevent cancer cells from growing. Necitumumab is a type of monoclonal antibody. Also called Portrazza

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski